Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A

Askar K Alshammari1,2, Meshach Maina1, Adam M Blanchard1

  • 1One Virology, Wolfson Centre for Global Virus Research, School of Veterinary Medicine and Science, Sutton Bonington Campus, University of Nottingham, College Road, Loughborough LE12 5RD, UK.

PubMed

Insights

Influenza A virus and Streptococcus bacteria co-infections involve protein interactions that worsen disease. Understanding these viral and bacterial protein interactions is key to mitigating severe secondary infections.

Area of Science:

  • Microbiology
  • Virology
  • Immunology

Background:

  • Influenza A virus infections increase susceptibility to secondary bacterial respiratory infections, often leading to severe outcomes.
  • Co-infections with influenza A virus and Streptococcus bacteria are characterized by protein-protein interactions that can exacerbate disease, promoting bacterial colonization, immune evasion, and tissue damage.

Purpose of the Study:

  • To conduct a scoping review evaluating evidence for protein-protein interactions between influenza A virus proteins and Streptococcus bacterial proteins.
  • To focus on the synergistic effects of proteins from different pathogens during co-infection.

Main Methods:

  • A comprehensive literature search was performed to identify studies on protein-protein interactions between influenza A virus and Streptococcus.
  • Inclusion criteria were applied to filter studies, with 32 studies meeting the requirements from an initial 2366 identified.

Main Results:

  • Viral and bacterial neuraminidases (NanA, NanB, NanC) facilitate bacterial adherence and colonization by desialylating host receptors.
  • Hemagglutinin (HA) from the virus modulates bacterial virulence factors, aiding bacterial internalization.
  • Pneumococcal surface proteins (PspA, PspK), M protein, and pneumolysin (PLY) contribute to immune evasion, increasing disease severity during co-infections.

Conclusions:

  • Understanding the interplay of viral and bacterial proteins during influenza co-infections is crucial.
  • Identifying these synergistic mechanisms offers potential therapeutic targets to reduce the severity of secondary bacterial infections.